Differential Impact of TMJ Disc Displacement and Muscle Disorders on Pain, Function, and Quality of Life in TMD Patients (DPTMD)

April 24, 2025 updated by: Sunil Kumar Vaddamanu, King Khalid University

Correlations Between Disc Position and the Key Clinical Outcomes in TMD Patients: Cross-sectional Study

This study aims to explore the relationship between the position of the temporomandibular joint (TMJ) disc and key clinical outcomes in patients with temporomandibular disorders (TMD). TMD is a condition that can cause pain, difficulty in jaw movement, and reduced quality of life. The research examines how disc displacement, as seen on MRI scans, correlates with pain levels, jaw function, and overall well-being. By better understanding these connections, the study seeks to provide insights that could improve the diagnosis and management of TMD, enhancing patient care and outcomes. This observational study involves non-invasive clinical and imaging assessments of TMD patients.

Study Overview

Detailed Description

This observational, cross-sectional study investigates the correlation between temporomandibular joint (TMJ) disc position and clinical outcomes in patients diagnosed with temporomandibular disorders (TMD). TMD encompasses conditions causing pain, jaw dysfunction, and diminished quality of life. The study evaluates disc displacement using magnetic resonance imaging (MRI) and measures clinical outcomes such as pain severity (Visual Analog Scale), functional limitations (Helkimo Index), and quality of life (Oral Health Impact Profile-14).

Participants include 100 individuals aged 18-65 with clinically confirmed TMD. Data collection involves clinical evaluations and MRI imaging to classify disc displacement into categories such as normal, with reduction, and without reduction. Statistical analyses, including correlation and regression, identify relationships between disc position and outcomes while accounting for confounding factors.

The findings aim to improve understanding of the pathophysiology of TMD and guide diagnostic and therapeutic strategies for better patient outcomes. The study adheres to ethical guidelines, ensuring informed consent and patient confidentiality.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bangalore, India
        • Sri Rajiv Gandhi College of Dental Sciences & Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of adults aged 18 to 65 years diagnosed with temporomandibular disorders (TMD). Participants are recruited from a multidisciplinary clinic specializing in TMD diagnosis and management. Eligible individuals present with clinical symptoms such as jaw pain, restricted movement, or clicking sounds in the temporomandibular joint (TMJ) and have their diagnosis confirmed through physical examination and MRI imaging. The study excludes individuals with systemic diseases affecting the TMJ, recent jaw trauma, prior TMJ surgeries, and conditions that may interfere with TMD diagnosis or imaging. The population is representative of patients seeking care for TMD, allowing for analysis of clinical and imaging correlations.

Description

Inclusion Criteria:

  1. Adults aged between 18 and 65 years.
  2. Diagnosed with temporomandibular disorders (TMD) based on clinical examination and imaging (MRI).
  3. Presence of at least one of the following symptoms:

    • Jaw pain
    • Restricted jaw movement
    • Clicking sounds in the temporomandibular joint (TMJ)
  4. No history of recent jaw or facial trauma.
  5. No systemic diseases affecting the TMJ or musculoskeletal system (e.g., rheumatoid arthritis).
  6. Able to provide informed consent.

Exclusion Criteria:

  1. History of major jaw or facial trauma within the last six months.
  2. Systemic conditions that might affect TMJ function, such as autoimmune diseases or bone disorders.
  3. Previous TMJ surgery or other major interventions.
  4. Pregnant or lactating women.
  5. Inability to undergo MRI due to contraindications (e.g., metal implants, pacemakers).
  6. Severe malocclusion or other dental/medical conditions interfering with TMD diagnosis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Normal Disc Position
Participants with an anatomically correct TMJ disc position as observed on MRI.
Disc Displacement with Reduction (DDwR)
Participants whose TMJ disc is displaced anteriorly at rest but returns to its normal position during mouth opening.
Disc Displacement without Reduction (DDwoR)
Participants whose TMJ disc remains displaced and does not return to its normal position during mouth opening

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Severity
Time Frame: Measured at the time of enrollment.
Pain severity will be assessed using the Visual Analog Scale (VAS), with scores ranging from 0 (no pain) to 10 (worst possible pain)
Measured at the time of enrollment.
Pain Severity
Time Frame: Measured at the time of enrollment.
Pain severity will be assessed using the Visual Analog Scale (VAS), but focused on the patient's retrospective assessment of the worst pain experienced within the last week.
Measured at the time of enrollment.
Pain Severity
Time Frame: Measured at the time of enrollment.
Pain severity will be assessed using the Visual Analog Scale (VAS), considering the patient's average pain experienced over the past month.
Measured at the time of enrollment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Limitations
Time Frame: Measured at the time of enrollment
Functional limitations will be evaluated using the Helkimo Index, assessing parameters such as jaw movement and mobility.
Measured at the time of enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sunil K Vaddamanu, MDS, snu@kku.edu.sa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 26, 2024

Primary Completion (Actual)

February 20, 2025

Study Completion (Actual)

February 22, 2025

Study Registration Dates

First Submitted

December 26, 2024

First Submitted That Met QC Criteria

January 2, 2025

First Posted (Actual)

January 3, 2025

Study Record Updates

Last Update Posted (Actual)

April 29, 2025

Last Update Submitted That Met QC Criteria

April 24, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual Participant Data (IPD) will not be shared because the study involves sensitive patient information, including clinical and imaging data, which are subject to strict privacy and confidentiality regulations. Additionally, the scope of the study does not include provisions for external data sharing, as the data is intended solely for the purposes of this research and its analysis. Access to the data is restricted to the research team to ensure compliance with ethical standards and institutional review board (IRB) requirements.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Disorders (TMD)

Subscribe